RUNX3 and acute promyelocytic leukemia: It has been reported that AML2 and AML1 expression can be induced by retinoic acid with ATRA having reduced effect on non-M3 AML (any type other than acute promyelocytic leukemia) as it acts on the RAR pathway[43], [44].